journal article·2017-06-07

Competitive Inhibition Mechanism of Acetylcholinesterase without Catalytic Active Site Interaction: Study on Functionalized C60Nanoparticles via in Vitro and in Silico Assays

Yanyan Liu, Bing Yan, David A. Winkler, Jianjie Fu, Aiqian Zhang

Publisher page

Abstract

Acetylcholinesterase (AChE) activity regulation by chemical agents or, potentially, nanomaterials is important for both toxicology and pharmacology. Competitive inhibition via direct catalytic active sites (CAS) binding or noncompetitive inhibition through interference with substrate and product entering and exiting has been recognized previously as an AChE-inhibition mechanism for bespoke nanomaterials. The competitive inhibition by peripheral anionic site (PAS) interaction without CAS binding remains unexplored. Here, we proposed and verified the occurrence of a presumed competitive inhibition of AChE without CAS binding for hydrophobically functionalized C 60 nanoparticles (NPs) by employing both experimental and computational methods. The kinetic inhibition analysis distinguished six competitive inhibitors, probably targeting the PAS, from the pristine and hydrophilically modified C 60 NPs. A simple quantitative nanostructure–activity relationship (QNAR) model relating the pocket accessible length of substituent to inhibition capacity was then established to reveal how the geometry of the surface group decides the NP difference in AChE inhibition. Molecular docking identified the PAS as the potential binding site interacting with the NPs via a T-shaped plug-in mode. Specifically, the fullerene core covered the enzyme gorge as a lid through π–π stacking with Tyr72 and Trp286 in the PAS, while the hydrophobic ligands on the fullerene surface inserted into the AChE active site to provide further stability for the complexes. The modeling predicted that inhibition would be severely compromised by Tyr72 and Trp286 deletions, and the subsequent site-directed mutagenesis experiments proved this prediction. Our results demonstrate AChE competitive inhibition of NPs without CAS participation to gain further understanding of both the neurotoxicity and the curative effect of NPs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Cholinesterase and Neurodegenerative Diseases · Computational Drug Discovery Methods · Fullerene Chemistry and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China

College of Resources and Environment, University of Chinese Academy of Sciences, Beijing 100190, China

School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, China

School of Environment, Guangzhou Key Laboratory of Environmental Exposure and Health and Guangdong Key Laboratory of Environmental Pollution and Health, Jinan University, Guangzhou 510632, China

CSIRO Manufacturing, Clayton 3168, Australia

Monash Institute of Pharmaceutical Sciences, Parkville 3052, Australia

Latrobe Institute for Molecular Science, Bundoora, 3046, Australia

School of Chemical and Physical Science, Flinders University, Bedford Park 5042, Australia

Funding

Ministry of Science and Technology of the People's Republic of China · National Natural Science Foundation of China · Chinese Academy of Sciences

References (69)

Show source-provided references
1. 10.1016/S0014-2999(98)00093-410.1016/S0014-2999(98)00093-4 ↗
2. 10.1021/ja021111w10.1021/ja021111w ↗
3. 10.1021/jm400990p10.1021/jm400990p ↗
4. 10.1155/2013/32121310.1155/2013/321213 ↗
5. 10.1016/j.chemosphere.2009.05.01510.1016/j.chemosphere.2009.05.015 ↗
6. 10.1016/j.aca.2014.11.02710.1016/j.aca.2014.11.027 ↗
7. 10.1021/jacs.5b1138410.1021/jacs.5b11384 ↗
8. 10.1021/jm061047j10.1021/jm061047j ↗
9. 10.1039/C6OB02120D10.1039/C6OB02120D ↗
10. 10.1039/C6NR08473G10.1039/C6NR08473G ↗
11. 10.1002/psc.297410.1002/psc.2974 ↗
12. 10.1016/j.snb.2009.09.05110.1016/j.snb.2009.09.051 ↗
13. 10.1021/ja106820e10.1021/ja106820e ↗
14. 10.1073/pnas.90.19.903110.1073/pnas.90.19.9031 ↗
15. 10.1021/ja051278010.1021/ja0512780 ↗
16. 10.1002/chem.20160167310.1002/chem.201601673 ↗
17. 10.1021/nn406337410.1021/nn4063374 ↗
18. 10.1002/cjoc.20118047910.1002/cjoc.201180479 ↗
19. 10.1038/ncomms1142910.1038/ncomms11429 ↗
20. 10.1186/1556-276X-7-43310.1186/1556-276X-7-433 ↗
21. 10.1002/cbic.20060023710.1002/cbic.200600237 ↗
22. 10.1021/acsami.5b1284810.1021/acsami.5b12848 ↗
23. 10.1002/anie.20161134910.1002/anie.201611349 ↗
24. 10.1002/anie.20150933210.1002/anie.201509332 ↗
25. 10.1016/1074-5521(95)90219-810.1016/1074-5521(95)90219-8 ↗
26. 10.1038/nnano.2008.13010.1038/nnano.2008.130 ↗
27. 10.1289/ehp.920910.1289/ehp.9209 ↗
28. 10.1016/j.tiv.2010.09.01010.1016/j.tiv.2010.09.010 ↗
29. 10.1073/pnas.94.17.943410.1073/pnas.94.17.9434 ↗
30. 10.1371/journal.pone.014776110.1371/journal.pone.0147761 ↗
31. 10.1021/ja046615410.1021/ja0466154 ↗
32. 10.3390/ijms1208496410.3390/ijms12084964 ↗
33. 10.1039/b604361e10.1039/b604361e ↗
34. 10.1021/nn901809b10.1021/nn901809b ↗
35. 10.2147/IJN.S5282910.2147/IJN.S52829 ↗
36. 10.1016/S0006-2952(02)01514-910.1016/S0006-2952(02)01514-9 ↗
37. 10.1021/acs.jcim.6b0064210.1021/acs.jcim.6b00642 ↗
38. 10.1007/s12274-014-0618-510.1007/s12274-014-0618-5 ↗
39. 10.1021/acs.chemrev.6b0080110.1021/acs.chemrev.6b00801 ↗
40. 10.1038/nature2203510.1038/nature22035 ↗
41. 10.1038/nature2061310.1038/nature20613 ↗
42. 10.1021/acs.jpcc.5b0998510.1021/acs.jpcc.5b09985 ↗
43. 10.1021/acs.jcim.6b0048210.1021/acs.jcim.6b00482 ↗
44. 10.1002/ijch.20160012710.1002/ijch.201600127 ↗
45. 10.1021/cr200066h10.1021/cr200066h ↗
46. 10.1016/0006-2952(61)90145-910.1016/0006-2952(61)90145-9 ↗
47. 10.1016/0003-2697(87)90590-210.1016/0003-2697(87)90590-2 ↗
48. 10.1073/pnas.72.10.383410.1073/pnas.72.10.3834 ↗
49. 10.1021/cr00081a00510.1021/cr00081a005 ↗
50. 10.1002/pro.556003020410.1002/pro.5560030204 ↗
51. 10.1016/0896-6273(90)90103-M10.1016/0896-6273(90)90103-M ↗
52. Krupka R. M. · Mol. Pharmacol. · 1966 · 2 · 55810.1016/S0026-895X(25)14847-5 ↗
53. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Keith, T.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K. V.; Zakrzewski, G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, O.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J.Gaussian 09, Revision B.01;Gaussian, Inc.:Wallingford, CT, 2010.
54. 10.1175/1520-0450(1970)009<0330:AMCMFT>2.0.CO;210.1175/1520-0450(1970)009<0330:AMCMFT>2.0.CO;2 ↗
55. 10.1016/0304-3800(93)90078-710.1016/0304-3800(93)90078-7 ↗
56. 10.1038/nprot.2016.05110.1038/nprot.2016.051 ↗
57. 10.1002/etc.38910.1002/etc.389 ↗
58. 10.1007/BF0012447410.1007/BF00124474 ↗
59. 10.1021/ci800063v10.1021/ci800063v ↗
60. 10.1002/smll.20070059510.1002/smll.200700595 ↗
61. 10.1021/bi982723p10.1021/bi982723p ↗
62. 10.1021/ja051278010.1021/ja0512780 ↗
63. 10.1021/jm040787u10.1021/jm040787u ↗
64. 10.1042/bj335009510.1042/bj3350095 ↗
65. 10.1093/emboj/cdg00510.1093/emboj/cdg005 ↗
66. 10.1073/pnas.030820610010.1073/pnas.0308206100 ↗
67. Shafferman A. · EMBO J. · 1992 · 11 · 356110.1002/j.1460-2075.1992.tb05439.x ↗
68. Barak D. · J. Biol. Chem. · 1994 · 269 · 629610.1016/S0021-9258(17)37371-4 ↗
69. Radic Z. · J. Biol. Chem. · 1994 · 269 · 1123310.1016/S0021-9258(19)78115-0 ↗